ID   SG223_HUMAN             Reviewed;        1406 AA.
AC   Q86YV5; Q8N3N5;
DT   28-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2014, sequence version 4.
DT   12-APR-2017, entry version 121.
DE   RecName: Full=Tyrosine-protein kinase SgK223;
DE            EC=2.7.10.2;
DE   AltName: Full=Sugen kinase 223;
GN   Name=SGK223;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 24-1406, AND VARIANTS GLN-404; LEU-569;
RP   CYS-578 AND THR-1113.
RC   TISSUE=Spleen;
RA   Jikuya H., Takano J., Nomura N., Kikuno R., Nagase T., Ohara O.;
RT   "The nucleotide sequence of a long cDNA clone isolated from human
RT   spleen.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 820-1406, AND VARIANT
RP   THR-1113.
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   IDENTIFICATION.
RX   PubMed=12471243; DOI=10.1126/science.1075762;
RA   Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S.;
RT   "The protein kinase complement of the human genome.";
RL   Science 298:1912-1934(2002).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-696 AND SER-745, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-745, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-826, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-148; SER-696 AND
RP   SER-826, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-148 AND SER-782, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-122; GLY-137; ILE-139; GLN-404;
RP   LEU-569; CYS-578; ALA-595; THR-662; LEU-814; ARG-851; LEU-1003;
RP   MET-1041; THR-1113 AND HIS-1315.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC068353; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC103957; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK122582; BAC56923.1; -; mRNA.
DR   EMBL; AL833872; CAD38729.1; -; mRNA.
DR   CCDS; CCDS43706.1; -.
DR   RefSeq; NP_001074295.2; NM_001080826.2.
DR   RefSeq; XP_005272426.2; XM_005272369.4.
DR   RefSeq; XP_005272427.2; XM_005272370.4.
DR   UniGene; Hs.583863; -.
DR   UniGene; Hs.657673; -.
DR   ProteinModelPortal; Q86YV5; -.
DR   BioGrid; 127591; 6.
DR   IntAct; Q86YV5; 7.
DR   MINT; MINT-1413315; -.
DR   STRING; 9606.ENSP00000330930; -.
DR   iPTMnet; Q86YV5; -.
DR   PhosphoSitePlus; Q86YV5; -.
DR   BioMuta; SGK223; -.
DR   DMDM; 327478560; -.
DR   EPD; Q86YV5; -.
DR   PaxDb; Q86YV5; -.
DR   PeptideAtlas; Q86YV5; -.
DR   PRIDE; Q86YV5; -.
DR   DNASU; 157285; -.
DR   GeneID; 157285; -.
DR   KEGG; hsa:157285; -.
DR   UCSC; uc064kbu.1; human.
DR   CTD; 157285; -.
DR   DisGeNET; 157285; -.
DR   GeneCards; SGK223; -.
DR   H-InvDB; HIX0007293; -.
DR   HPA; HPA012066; -.
DR   MIM; 617344; gene.
DR   neXtProt; NX_Q86YV5; -.
DR   OpenTargets; ENSG00000275342; -.
DR   eggNOG; ENOG410IJMD; Eukaryota.
DR   eggNOG; ENOG4110SRP; LUCA.
DR   GeneTree; ENSGT00460000041554; -.
DR   HOGENOM; HOG000168455; -.
DR   HOVERGEN; HBG055817; -.
DR   InParanoid; Q86YV5; -.
DR   KO; K17537; -.
DR   OMA; TWHRLHP; -.
DR   OrthoDB; EOG091G03K2; -.
DR   SignaLink; Q86YV5; -.
DR   ChiTaRS; SGK223; human.
DR   GenomeRNAi; 157285; -.
DR   PRO; PR:Q86YV5; -.
DR   Proteomes; UP000005640; Unplaced.
DR   Bgee; ENSG00000182319; -.
DR   Genevisible; Q86YV5; HS.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004672; F:protein kinase activity; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transferase;
KW   Tyrosine-protein kinase.
FT   CHAIN         1   1406       Tyrosine-protein kinase SgK223.
FT                                /FTId=PRO_0000263008.
FT   DOMAIN      978   1329       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     984    992       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COMPBIAS     55     58       Poly-Pro.
FT   COMPBIAS    713    718       Poly-Pro.
FT   ACT_SITE   1145   1145       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING    1024   1024       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     148    148       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     413    413       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q571I4}.
FT   MOD_RES     696    696       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     745    745       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     782    782       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     826    826       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT     122    122       L -> I (in dbSNP:rs55764617).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041803.
FT   VARIANT     137    137       R -> G (in dbSNP:rs56290960).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041804.
FT   VARIANT     139    139       V -> I (in dbSNP:rs34346032).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041805.
FT   VARIANT     404    404       R -> Q (in dbSNP:rs3896980).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_041806.
FT   VARIANT     569    569       P -> L (in dbSNP:rs4840955).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_041807.
FT   VARIANT     578    578       S -> C (in dbSNP:rs4840953).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_041808.
FT   VARIANT     595    595       P -> A (in dbSNP:rs55994745).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041809.
FT   VARIANT     662    662       P -> T (in dbSNP:rs56351643).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041810.
FT   VARIANT     814    814       P -> L (in dbSNP:rs56207906).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041811.
FT   VARIANT     851    851       H -> R (in dbSNP:rs56215812).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041812.
FT   VARIANT    1003   1003       S -> L (in dbSNP:rs56289289).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041813.
FT   VARIANT    1041   1041       V -> M (in dbSNP:rs28533138).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041814.
FT   VARIANT    1113   1113       A -> T (in dbSNP:rs12549973).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:17974005,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_041815.
FT   VARIANT    1315   1315       R -> H. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041816.
FT   CONFLICT   1226   1226       G -> S (in Ref. 2; BAC56923 and 3;
FT                                CAD38729). {ECO:0000305}.
SQ   SEQUENCE   1406 AA;  149624 MW;  941BCF315B826148 CRC64;
     MHQTLCLNPE SLKMSACSDF VEHIWKPGSC KNCFCLRSDH QLVAGPPQPR AGSLPPPPRL
     PPRPENCRLE DEGVNSSPYS KPTIAVKPTM MSSEASDVWT EANLSAEVSQ VIWRRAPGKL
     PLPKQEDAPV VYLGSFRGVQ KPAGPSTSPD GNSRCPPAYT MVGLHNLEPR GERNIAFHPV
     SFPEEKAVHK EKPSFPYQDR PSTQESFRQK LAAFAGTTSG CHQGPGPLRE SLPSEDDSDQ
     RCSPSGDSEG GEYCSILDCC PGSPVAKAAS QTAGSRGRHG GRDCSPTCWE QGKCSGPAEQ
     EKRGPSFPKE CCSQGPTAHP SCLGPKKLSL TSEAAISSDG LSCGSGSGSG SGASSPFVPH
     LESDYCSLMK EPAPEKQQDP GCPGVTPSRC LGLTGEPQPP AHPREATQPE PIYAESTKRK
     KAAPVPSKSQ AKIEHAAAAQ GQGQVCTGNA WAQKAASGWG RDSPDPTPQV SATITVMAAH
     PEEDHRTIYL SSPDSAVGVQ WPRGPVSQNS EVGEEETSAG QGLSSRESHA HSASESKPKE
     RPAIPPKLSK SSPVGSPVSP SAGGPPVSPL ADLSDGSSGG SSIGPQPPSQ GPADPAPSCR
     TNGVAISDPS RCPQPAASSA SEQRRPRFQA GTWSRQCRIE EEEEVEQELL SHSWGRETKN
     GPTDHSNSTT WHRLHPTDGS SGQNSKVGTG MSKSASFAFE FPKDRSGIET FSPPPPPPKS
     RHLLKMNKSS SDLEKVSQGS AESLSPSFRG VHVSFTTGST DSLASDSRTC SDGGPSSELA
     HSPTNSGKKL FAPVPFPSGS TEDVSPSGPQ QPPPLPQKKI VSRAASSPDG FFWTQGSPKP
     GTASPKLNLS HSETNVHDES HFSYSLSPGN RHHPVFSSSD PLEKAFKGSG HWLPAAGLAG
     NRGGCGSPGL QCKGAPSASS SQLSVSSQAS TGSTQLQLHG LLSNISSKEG TYAKLGGLYT
     QSLARLVAKC EDLFMGGQKK ELHFNENNWS LFKLTCNKPC CDSGDAIYYC ATCSEDPGST
     YAVKICKAPE PKTVSYCSPS VPVHFNIQQD CGHFVASVPS SMLSSPDAPK DPVPALPTHP
     PAQEQDCVVV ITREVPHQTA SDFVRDSAAS HQAEPEAYER RVCFLLLQLC NGLEHLKEHG
     IIHRDLCLEN LLLVHCTLQA GPGPAPAPAP APAPAAAAPP CSSAAPPAGG TLSPAAGPAS
     PEGPREKQLP RLIISNFLKA KQKPGGTPNL QQKKSQARLA PEIVSASQYR KFDEFQTGIL
     IYELLHQPNP FEVRAQLRER DYRQEDLPPL PALSLYSPGL QQLAHLLLEA DPIKRIRIGE
     AKRVLQCLLW GPRRELVQQP GTSEEALCGT LHNWIDMKRA LMMMKFAEKA VDRRRGVELE
     DWLCCQYLAS AEPGALLQSL KLLQLL
//
